Myocardial ischemic preconditioning for 5 marks anesthesia residency
Reading File
Now let me search the medical library for ischemic preconditioning content in parallel:
Finding Sources
Finding Sources
Searching PubMed
"myocardial ischemic preconditioning" AND "anesthesia"
Found the key reference in Miller's Anesthesia. Let me read that section now:
Reading File
Finding Sources
Excellent! Found key content in Miller's and Barash. Let me now read those sections in detail:
Reading File
Reading File
Let me now read the key cardioprotection section from Barash and also find the dedicated IPC section in Miller's:
Reading File
Finding Sources
Now let me read the key IPC content from Miller's block 7 (coronary circulation section) and also the Yamada IPC section:
Reading File
Reading File
Reading File
I now have comprehensive content. Let me do one more targeted search for the signaling cascade and KATP channel details from Braunwald's and Fuster's:
Finding Sources
Now let me read the dedicated IPC section from Morgan & Mikhail (most exam-relevant anesthesia textbook) and Fuster's section:
Reading File
Reading File
I now have all the information needed from authoritative anesthesia textbooks. Let me compile a comprehensive, exam-ready answer.
Myocardial Ischemic Preconditioning
(5-mark answer for anesthesia residency)
Definition
Ischemic preconditioning (IPC) is the phenomenon whereby brief, sublethal episodes of myocardial ischemia followed by reperfusion render the myocardium resistant to injury from a subsequent, more prolonged ischemic insult - resulting in a significant reduction of infarct size. It was first described by Murry et al. (1986) in the canine myocardium and has since been demonstrated in brain, intestine, kidney, and skeletal muscle.
- Morgan & Mikhail's Clinical Anesthesiology, 7e - a brief ischemic episode "protects a cell from future, more pronounced ischemic events"
- Fuster and Hurst's The Heart, 15th ed - "repeated brief episodes of coronary occlusion preceding a prolonged coronary occlusion with reperfusion reduce infarct size"
Two Windows (Phases) of Protection
| Feature | Early (Classic) IPC | Late (Delayed) IPC |
|---|---|---|
| Onset | Within minutes of the IPC stimulus | ~24 hours later |
| Duration | 1 to 4 hours | 2 to 4 days ("second window of protection") |
| Mechanism | Uses pre-existing effector molecules (KATP channel opening, PKC activation) | Requires new gene expression and protein synthesis |
| Magnitude | More powerful | Less powerful, but sustained |
(Yamada's Textbook of Gastroenterology, 7e; Miller's Anesthesia, 10e)
Mechanism / Signaling Cascade
The IPC mechanism is multifocal and involves:
1. Triggers released during brief ischemia:
- Adenosine (A1 receptor activation)
- Opioids (k- and delta-opioid receptor activation)
- Bradykinin
- Reactive oxygen species (ROS) - paradoxically protective in small amounts
- Nitric oxide
2. Signal transduction:
- These triggers activate Protein Kinase C (PKC) and PI3K/Akt/eNOS pathways
- PKC activation opens sarcolemmal and mitochondrial KATP channels
3. End-effectors (cardioprotective outcomes):
- KATP channel opening --> reduced mitochondrial Ca²+ overload
- Reduced Ca²+ accumulation --> improved contractile recovery post-reperfusion
- Mitochondria become more permeable to ATP precursors
- Stabilization of the mitochondrial permeability transition pore (mPTP) - prevents its opening on reperfusion, which is the final common pathway of cell death
- 30-40% of cardioprotection from volatile anesthetics is attributed to reduced Ca²+ loading
(Barash Clinical Anesthesia, 9e; Morgan & Mikhail, 7e)
Forms of Preconditioning Relevant to Anesthesia
1. Classical (Direct) IPC
- Brief coronary occlusion + reperfusion cycles performed surgically before a sustained ischemic period (e.g., during CABG)
2. Anesthetic Preconditioning (APC)
- Volatile anesthetics (isoflurane, sevoflurane, desflurane) mimic IPC - termed "anesthetic preconditioning"
- Mechanism: diffuse through myocardial cell membranes --> alter mitochondrial electron transport --> form ROS --> trigger PKC --> open KATP channels
- Can be applied before the ischemic insult (preconditioning) or immediately after (postconditioning)
- Cardioprotection persists beyond elimination of the anesthetic
- Studies in CABG patients confirm reduced myocardial injury markers with volatile agents vs. propofol-based TIVA
3. Opioid-induced Preconditioning
- Morphine and other opioids mimic IPC through k- and delta-opioid receptor activation
- Reduces infarct size comparable to classic IPC
- Involves adenosine A1 receptors and PKC
- Late preconditioning is also produced by morphine (24 hours after administration)
- Intrathecal morphine has also been shown to produce comparable cardioprotection
4. Remote Ischemic Preconditioning (RIPC)
- Brief ischemia of a distant organ (limb, intestine, kidney) provides equivalent cardioprotection to direct IPC
- Clinical application: inflating a blood pressure cuff on the arm to 200 mmHg for 5-minute cycles
- Mediated by myocardial k-opioid receptors
- Multiple RCTs in CABG patients have evaluated RIPC; results have been inconsistent
(Miller's Anesthesia, 10e; Barash Clinical Anesthesia, 9e)
Postconditioning
- Brief coronary occlusion cycles applied during early reperfusion (not before ischemia) also reduces infarct size
- This is the reperfusion analog of preconditioning
- Volatile anesthetics administered solely on reperfusion also confer postconditioning protection
- Morphine enhances isoflurane-induced postconditioning via PI3K and opioid receptor activation
(Fuster and Hurst's The Heart, 15th ed; Miller's Anesthesia, 10e)
Clinical Relevance in Anesthesia
| Scenario | Application |
|---|---|
| CABG surgery | Volatile anesthetics preferred over TIVA for cardioprotection |
| High-risk cardiac patients for non-cardiac surgery | Volatile agents reduce perioperative myocardial injury |
| RIPC | Simple, non-invasive - BP cuff cycles on limb before cardiac surgery |
| Opioid use in cardiac anesthesia | Morphine/remifentanil contribute to myocardial protection |
| Xenon | NMDA receptor antagonism + KATP channel opening provides preconditioning |
Summary Points for Exam
- First described in canine myocardium (Murry, 1986)
- Two windows - early (1-4 hr, pre-existing molecules) and late (24hr onset, 2-4 days, requires gene expression)
- Key mediators: Adenosine, opioids, bradykinin, ROS, NO
- Signal transduction: Triggers --> PKC --> KATP channel opening --> mitochondrial Ca²+ protection --> mPTP stabilization
- Volatile anesthetics = anesthetic preconditioning (preferred over propofol in cardiac surgery)
- RIPC = simple limb cuff cycles; clinical benefit inconsistent in large RCTs
- Postconditioning = same protection applied at the START of reperfusion
- Opioids, adenosine, nicorandil (KATP channel opener), and volatile agents are all pharmacologic mimics of IPC
Sources: Miller's Anesthesia 10e | Barash Clinical Anesthesia 9e | Morgan & Mikhail's Clinical Anesthesiology 7e | Fuster and Hurst's The Heart 15e
This is a shared conversation. Sign in to Orris to start your own chat.